Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Bortezomib × Clear all

NCT00061932 2021-02-02

Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach

Phase 2 Completed

41 enrolled 8 charts

Gastrointestinal

Stomach Neoplasms